Health & Life Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 10, 2023 at 06:14 pm EDT
Share
Health & Life Co., Ltd. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was TWD 141.81 million compared to TWD 180.34 million a year ago. Net loss was TWD 17.79 million compared to net income of TWD 0.337 million a year ago. Basic loss per share from continuing operations was TWD 0.38 compared to basic earnings per share from continuing operations of TWD 0.01 a year ago. Diluted loss per share from continuing operations was TWD 0.38 compared to diluted earnings per share from continuing operations of TWD 0.01 a year ago.
For the six months, sales was TWD 272.07 million compared to TWD 327.33 million a year ago. Net loss was TWD 29.83 million compared to TWD 11.12 million a year ago. Basic loss per share from continuing operations was TWD 0.63 compared to TWD 0.23 a year ago. Diluted loss per share from continuing operations was TWD 0.63 compared to TWD 0.23 a year ago.
Health & Life Co., Ltd. is a Taiwan-based company principally engaged in the manufacture and distribution of medical equipment. The Company's mainly provides electronic sphygmomanometers, such as blood pressure monitors, nebulizers and blood glucose monitoring systems, which are used to measure and record systolic and diastolic blood pressure and glucose of human beings. The Company distributes its products within domestic market and to overseas markets.
HEALTH & LIFE CO., LTD. 
